• Helping you understand who owns the world, and how you can invest in it.
  • Follow us

SAB Biotherapeutics, Inc.

SAB Biotherapeutics, Inc.

Public
SABS
United States
SectorHealthcare
CountryUnited States
Market cap259.32M
A clinical-stage biopharmaceutical company developing human immunotherapies using transgenic cattle.

Where to buy SAB Biotherapeutics, Inc. (SABS)

SABS trades on these platforms. Substox may earn a commission if you open an account through one of these links, at no cost to you. It never changes what the data on this page says. Substox is not a licensed financial adviser and this is not investment advice.

Similar public companies in Healthcare